SYRS
Syros Pharmaceuticals, Inc. Common Stock
SYRS
SYRS
Delisted
SYRS was delisted on the 19th of March, 2025.
76 hedge funds and large institutions have $246M invested in Syros Pharmaceuticals, Inc. Common Stock in 2018 Q3 according to their latest regulatory filings, with 8 funds opening new positions, 25 increasing their positions, 25 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
76
Holders Change
–
Holders Change %
0%
% of All Funds
1.74%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
8
Increased
25
Reduced
25
Closed
8
Calls
$464K
Puts
$279K
Net Calls
+$185K
Net Calls Change
+$308K
Top Buyers
Top Sellers
| 1 |
Millennium Management
New York
|
-$2.41M |
| 2 |
Renaissance Technologies
New York
|
-$1.63M |
| 3 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$1.59M |
| 4 |
Point72 Asset Management
Stamford,
Connecticut
|
-$1.01M |
| 5 |
Two Sigma Investments
New York
|
-$715K |
